Latest AI and machine learning research in prostate cancer for healthcare professionals.
The non-invasive diagnosis and risk stratification of prostate cancer (PCa) remain clinically challenging due to the limited specificity of prostate-specific antigen (PSA). In this retrospective study, we applied a comparative machine learning (ML) framework to rank and select biomarkers from serum 1H nuclear magnetic resonance (NMR)-based metabolomics, subsequently developing three sequential met...
BACKGROUND: Resective epilepsy surgery has been proven to reduce the number of seizures and improve quality of life in patients with drug-resistant epilepsy (DRE) but implies high direct costs. Cost-effectiveness analyses have shown that surgery is cost-effective. We aimed to evaluate whether we can determine the cost-effectiveness of surgery for DRE using artificial intelligence-based extraction ...
The Extracellular Vesicles Gene-based Prostate Score (EGPS), powered by DeepSeek, is an artificial intelligence (AI) diagnostic tool that enhances the...
PURPOSE OF REVIEW: Biochemical recurrence (BCR) after radical prostatectomy occurs in up to one-third of patients and increases the risk of metastasis...
OBJECTIVE: We evaluated a commercial artificial intelligence (AI) system as a concurrent decision-support tool for clinically significant prostate can...
INTRODUCTION: Prostate-specific antigen (PSA) alone is insufficient for the diagnosis of prostate cancer (PCa), particularly within the gray zone rang...
Prostate cancer (PCa) remains a major global health burden, with incidence rising as populations age. The molecular, histological, and patient-specifi...
Accurate early detection of clinically significant prostate cancer is crucial for improving patient outcomes. However, traditional diagnostic methods ...
It is imperative to identify patients with prostate cancer (PCa) who will not benefit from androgen receptor signaling inhibitors and to improve their...
Psoriatic arthritis (PsA) lacks reliable biomarkers to support early diagnosis and disease stratification. This study aimed to identify protein signat...
Benign Prostatic Hyperplasia (BPH) is a common condition among aging men that often causes significant urinary symptoms, impacting their quality of li...
BACKGROUND AND PURPOSE: This study aimed to predict the treatment outcomes and survival of patients with locally advanced cervical cancer (LACC) recei...
PURPOSE: To have an insight into language-related functional connectivity in post-stroke aphasia (PSA) from graph theory measurements when performing ...
Integrating multimodal data, such as unstructured clinical narratives and quantitative blood biomarkers, remains a major challenge in modern healthcar...
OBJECTIVE: To assess prostate volume (PV) changes with age in symptomatic and asymptomatic men with and without clinically significant prostate cancer...
Against the backdrop of addressing climate change and reducing carbon emissions, carbon dioxide capture technology has gained increasing significance ...
Prostate cancer is among the most diagnosed malignancies in men worldwide and a leading cause of cancer-related mortality. Early and accurate diagnosi...
Biochemical recurrence (BCR) is a critical factor affecting the prognosis of prostate cancer (PCa) patients, while T cell exhaustion and metastatic pr...
OBJECTIVES: The study aimed to assess the predictive performance of transition zone PSA density (TZ-PSAD) compared to conventional PSA density (PSAD) ...
Raman spectroscopy (RS) is a label-free, non-destructive optical modality that provides a detailed profile of the molecular composition of a sample. T...